GL1X · GenesisL1 explorer

MolNFT v1 · #187924 · protein

Co-crystal structure of human PRMT9 in complex with MT221 inhibitor

7T39: “Co-crystal structure of human PRMT9 in complex with MT221 inhibitor”. X-ray diffraction, 1 ligand (EJB). MolNFT v1 #187924 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

PDB
7T39
Type
protein
Length
613 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
Q6P2P2
Ligands
EJB

Structure

x-ray diffraction · 1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein613—Q6P2P2

Ligands and binding sites

  • EJB · 7-[5-S-(4-{[(2-ethylpyridin-3-yl)methyl]amino}butyl)-5-thio-beta-D-ribofuranosyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 7T39 · Co-crystal structure of human PRMT9 in complex with MT221 inhibitor · the same entry in another collection · chain A against A, TM-score 1.00
  • Q6P2P2 · AlphaFold monomer V2.0 prediction for protein arginine N-methyltransferase 9 (Q6P2P2) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.